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Abstract 
Adverse events in hospitals cause significant morbidity and mortality, and considerable effort 
has been invested into analysing their incidence and preventability.  An unresolved issue in 
models of medical adverse events is potential endogeneity of length of stay (LOS): whilst the 
probability of suffering a medical adverse event during the episode is likely to increase as a 
patient stays longer, there are a range of unobservable patient and hospital factors affecting 
both the occurrence of adverse events and LOS, such as unobserved patient complexity and 
hospital management.  Therefore, statistical models of adverse events which do not account 
for the potential endogeneity of LOS may generate biased estimates. 
Our objective is to examine the effects of risk factors on the incidence of adverse events 
using  structural  equation  models  and  accounting  for  endogeneity  of  LOS.    We  estimate 
separate models for three of the most common and serious types of medical adverse events: 
adverse drug reactions, hospital acquired infections, and pressure ulcers.  We use episode 
level administrative hospital data from public hospitals in the state of Victoria, Australia, for 
the years 2004/05 and 2005/06 with detailed information on patients, in particular medical 
complexity  and  adverse  events  suffered  during  admission.    We  use  days  and  months  of 
discharge as instruments for LOS.  Our research helps assessing the costs and benefits of 
additional days spent in hospital.  For example, it can contribute to identifying the ideal time 
of  discharge  of  patients,  or  inform  whether  ‗hospital  at  home‘  programs  reduce  rates  of 
hospital acquired infections.   
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hospital quality  
JEL Classification: I11, D21, C3, H4, L3 3 
 
1. Introduction 
Adverse events during hospital admission affect nearly one out of 10 patients  (de Vries, 
Ramrattan et al. 2008).  An adverse event (AE) can be defined as an unintended injury or 
complication resulting in prolonged hospital stay, disability at the time of discharge or death 
and caused by healthcare management rather than by the patient‘s underlying disease process 
(Thomas, Studdert et al. 2000).  AEs are now widely agreed to be a serious problem.  They 
are suspected of killing more people than motor vehicle accidents, breast cancer, or AIDS in 
each year, and total costs of preventable AEs have been estimated between $17 billion and 
$29 billion for the USA (Kohn, Corrigan et al. 2000).  Thus, prevention of AEs promises 
significant societal benefits, and over the last two decades, increasing research effort has been 
invested to analyse the incidence of AEs, understand why they occur and how they could be 
prevented (for a systematic review see de Vries, Ramrattan et al. 2008).   
Commonly identified causes of AEs are medical or diagnostic errors, technical failures, poor 
hospital  procedures,  or  poor  communication  between  medical  staff  (Neale  and 
Woloshynowych 2003).  Major risk factors for AEs are patient characteristics, with sicker 
and older patients more likely to suffer AEs.  In recent years, efforts to prevent AEs have 
shifted from the person approach—blaming individuals for errors—to the ‗systems approach‘ 
(Dankelman and Grimbergen 2005).  The systems approach assumes that people will make 
mistakes, and that the system (hospital) that surrounds them should provide a safety net for 
these mistakes.  The systems approach aims to reduce the complexity of providing medical 
care,  by  -for  example-  standardization  of  procedures  and  medical  equipment,  checklists, 
quality testing of equipment, and staff training.   
Analysis of the causes and risk factors of AEs is important to help prevent them.  It allows 
targeting efforts to patients, medical procedures, and hospitals most at risk.  To date, causes 
and risk factors for AEs have mostly been identified by qualitative research (Michel, Quenon 
et al. 2004).  Usually, a team of medical experts analyse patient records retrospectively to 
judge  whether  an  AE  has  occurred,  and  what  the  reason  may  have  been.    Due  to  the 
subjective nature of this process, record reviews are said to have only modest reliability in 
identifying the incidence and causes of AEs (Localio, Weaver et al. 1996; Walshe 1998).  An 
additional, and perhaps more serious, shortcoming of record reviews is that they use small 
and non-random samples of hospitals and patients.  For example, of the studies reviewed by 
de Vries, Ramrattan, et al (2008), about half collect data from only one or two hospitals.  4 
 
Because the reviewed patients and hospitals may have particular characteristics not present in 
other patients and hospitals in a health system, it is problematic to generalize results from 
record reviews.  They should be supplemented with quantitative research based on random 
samples (or even the population) of patients and hospitals to inform an evidence based system 
level approach for prevention of AEs in all hospitals. 
In this paper, we use a statistical analysis of administrative hospital data to establish the 
relationship between the incidence and risk factors of three of the most common and serious 
types of medical adverse events: adverse drug reactions, hospital acquired infections, and 
pressure ulcers.  Those complications are relatively common, create considerable morbidity 
and mortality, and a large percentage of them are considered preventable under optimal care 
(Lazarou, Pomeranz et  al.  1998;  Neale and Woloshynowych 2003;  Unruh 2003;  Aranaz-
Andres, Aibar-Remon et al. 2008).  We model AEs as a function of patient risk factors, 
hospital characteristics, and length of stay in hospital (LOS).  An important feature of our 
analysis is that we include LOS as a risk factor for AE, and that we estimate a two-equation 
system model allowing for the potential endogeneity of LOS.  As detailed in the next section, 
there  is  a  policy  motivation  for  estimating  the  marginal  impact  of  LOS  on  AE,  and  the 
correlation  via  common  unobservable  patient,  specialty  and  hospital  factors  needs  to  be 
accounted for.  While our approach does not allow the depth of analysis provided by record 
reviews,  it  has  the  advantage  that  results  can  be  generalized,  and  that  it  is  relatively 
inexpensive.    Most  importantly,  and  unlike  a  qualitative  research  approach,  a  statistical 
analysis can generate and test quantitative estimates of the impact of particular risk factors 
and inform on their relative importance -conditional on all others.   
 
2. Length of Stay as an Endogenous Risk Factor of Adverse Events 
There is only limited evidence on the quantitative impact of one of the most important risk 
factors  for  suffering  adverse  events:  Length  of  Stay.    Intuitively,  each  additional  day  in 
hospital increases the probability of suffering a medical AE during the episode.
 1  Van den 
Bemt et al. (2000) find a comparably high incidence of adverse drug events, and comment 
                                                           
1 LOS is only a potential risk factor for medical adverse events which occur during ward care, such as adverse 
drug events and hospital acquired infections.  Most operation-related adverse events, such as surgical errors or 
bleeding, are likely to occur at the beginning of the episode, and are thus unaffected by LOS.   
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that may be due to the fact that ―the length of hospitalization in this study was relatively long, 
so there may have been simply more time for adverse drug events to occur‖.  Weingart et al. 
(2000) comment that ―the characteristics of patients may be less important than the duration 
of care in  explaining adverse events‖.   Bates et  al.  (1999) find that adverse drug events 
increase with LOS, and Andrews et al. (1997) estimate that each additional day in hospital 
increases the probability of suffering an AE by 6%, although these estimates seem to be 
based on correlation and not causal analyses.   
Our proposed approach informs on how likely it is to suffer an AE during one or several days 
in hospital for an average patient, holding all other risk factors constant.  This can contribute 
to calculating the expected costs and benefits of days spent in hospital, of which the expected 
costs of AEs is one component.  If expected costs are relatively high, i.e. AEs are relatively 
common and/or associated with high cost, it may influence hospital managers to discharge 
patients earlier, or transfer them to alternative care.  This may be advantageous if expected 
cost of AEs is lower in alternative care, but other costs and benefits similar.  Examples of 
alternative care programs are ‗early discharge‘ and ‗hospital at home‘ programs which are 
piloted  in  many  countries,  usually  for  patients  with  chronic  or  terminal  conditions  (Leff 
2009).  Many of these programs are associated with greater patient satisfaction and lower AE 
rates,  in  particular  lower  infection  rates,  but  they  have  longer  overall  LOS  (Graham, 
Keldermans et al. 1991; Leff, Burton et al. 2005; Shepperd, Doll et al. 2009).  If treatment 
programs  differ  with  respect  to  LOS  and  AE  rates,  it  is  difficult  to  use  Randomized 
Controlled Trials to assess the impact of such programs on AEs.  This is because patients 
cannot be randomized on the risk factor LOS if it is associated with the treatment.  Our 
proposed  statistical  analysis  can  overcome  this  problem,  and  could  be  used  to  analyse 
whether and by how much ‗early discharge‘ and ‗hospital at home‘ programs reduce infection 
rates, controlling both for differences in LOS and other risk factors.  Our approach could also 
be  used  to  incorporate  the  expected  costs  of  AEs  into  the  design  of  optimal  treatment 
protocols (including recommended LOS) for different conditions (Fine, Medsger et al. 1997; 
Howard, Evans et al. 1999).   
Of course it is not the days in hospital itself, but what happens during those days that cause 
AEs.    Ultimately,  discharging  patients  with  the  objective  to  reducing  AEs  seems 
unsatisfactory compared to tackling the above mentioned causes of AEs.  However, some 
types of AEs are more difficult to prevent than others, especially if they are caused by factors 
which cannot be changed unless under very high costs or factors which cannot be changed in 6 
 
the short run.   For example,  a  given building  infrastructure may  require  accommodating 
patients in rooms with multiple beds, which increases the risk of spread of infections; an 
effective antibiotic to treat a particular type of infection may be unavailable temporarily.  In 
these situations, LOS is a risk factor for AEs which can be quickly and directly influenced by 
the actions of hospital management.   
A problem in a statistical model of medical adverse events is potential endogeneity of LOS.  
It is very likely that there are a range of unobservable hospital and patient factors affecting 
both  the  occurrence  of  AEs  and  LOS.    Examples  are  unobserved  hospital  management, 
patient complexity, and risks associated with particular medical procedures.  Well managed 
hospitals may be more successful in implementing safety procedures to prevent AEs, but also 
better  at  planning  bed  occupancy  to  reduce  overall  LOS.    This  would  imply  that  ‗good 
management‘ decreases LOS and rates of AEs.  On the other hand, hospitals may have very 
high occupancy rates, resulting in shorter LOS, high demands on staff and greater likelihood 
of AEs, leading to an inverse relation between LOS and AEs.  Unobserved patient complexity 
is likely to increase both LOS and the likelihood of AEs.  This implies that the error terms 
embodying effects of common unobservable factors on both LOS and AE are correlated and 
LOS is endogenous in the analysis of AEs.  A statistical model which does not account for 
the  potential  endogeneity  of  LOS  may  generate  inconsistent  and  biased  estimates  of  all 
factors impacting on AEs.
2   
 
3. The Model 
We estimate a system model consisting of a structural equation for AE and a reduced form 
equation for LOS, with additional instruments for the reduced form equation.  We use the day 
of the week and the month of the year a patient was discharged as extra instruments for LOS. 
As discussed in Section 5, there is evidence that these are associated with LOS, but not AEs, 
thus making them relevant and exogenous instruments.   
 
                                                           
2 Some medical studies analyse AEs per unit of time spent in hospitals, e.g. per 100 patient days, see Aranaz-
Andres, J. M., C. Aibar-Remon, et al. (2008). "Incidence of adverse events related to health care in Spain: 
results of the Spanish National Study of Adverse Events." Journal of Epidemiology and Community Health 
62(12): 1022-1029.  This approach solves the problem of endogeneity by creating a ratio of the two endogenous 
variables, but does not provide a structural estimate of the impact of LOS on the probability of AEs.   
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We specify a two-equation system model that jointly determines the probability of a patient 
having at least one adverse event of a certain type during a hospital episode and the length of 
hospital  stay  for  that  episode.    Let  * ( * ( , )    AE AE   be  a  latent  variable  that  is 
proportional to the propensity of having adverse events and is determined by 
 
*
1 1 1 () i i i i i AE X H LOS e        ,   (1) 
where  i X  is a vector of exogenous covariates including observable patient characteristics for 
episode  i,  1, ( ,..., ) i ki K i H H H    is a vector of fixed effect hospital dummy variables, with 
1 ki H   (k=1,...,K) if episode i took place in hospital k and  0 ki H   otherwise,  i LOS  is the 
length of stay of episode i,  1  ,  1  and   are coefficients to be estimated, and  1i e  is the error 
term  representing  effects  of  unobservable  patient  and  hospital  factors  for  episode 
 ( 1,..., )  i i N .  The latent variable  * AE  is unobservable and is mapped to the observable 




1         if  0  (for having at least one adverse event)










  (2) 
The length of stay variable  i LOS  in (1) is given by a reduced form equation 
2 2 2 i i i i i LOS X H Z e        ,         (3) 
where  i X  is defined as above,  i Z  is a vector of additional instruments,  2  ,  2  and    are 
unknown  coefficients,  and  2i e   is  the  error  term.    Assume  that  the  two  error  terms 
12 ( , ) ( 1,..., ) ii e e i N   are independent and identically distributed across all  N episodes and 
jointly  follow  a  bivariate  normal  distribution  with  11 1     for  identification,  22    as  the 
variance of  2i e , and   as the correlation coefficient for the two error terms.  
Equations (1)-(3) define a system model consisting of a mixture of a Probit equation and a 
regression equation that jointly determines the probability of adverse events and the length of 
stay  during  a  hospital  episode.    When  0   ,  the  correlation  between  the  common 
unobservable  factors  of  the  same  episode,  including  unobservable  patient,  specialty  and 
hospital characteristics, that affect both  i AE  and  i LOS  is quantified, and the structural effect 
of  i LOS  on  i AE  (i.e.  ) in equation (1) can be estimated allowing for the endogeneity of 
i LOS .  We estimate the system model separately for three types of AEs: adverse drug events, 
infections, and ulcers.  For comparison, we estimate (1) as univariate probit models which 8 
 
assume  LOS  is  exogenous.    The  models  are  estimated  using  the  maximum  likelihood 
estimator and Stata 10 (2007).    
 
4. Data and Specification of Variables 
We use the Victorian Admitted Episodes Data (VAED) for public hospitals in the state of 
Victoria,  Australia,  for  two  years  2004/05  and  2005/06  (Department  of  Human  Services 
2007).    The  VAED  are  administrative  hospital  data  of  high  quality  as  hospitals  have  a 
financial incentive to generate detailed records of all their patients because they receive the 
largest part of their budget via casemix funding.  Our sample consists of around 200,000 
episodes  per  year  in  medical  ‗Diagnosis-related  Groups‘,  which  are  defined  on  basis  of 
patients‘  diagnoses,  procedures  undertaken  and  other  patient  information  (Department  of 
Health 2005).  Each episode starts with a patient‘s admission to a hospital department and 
ends with discharge from that department.  We exclude maternity episodes, patients under 18 
years of age, dialysis, radiology, chemotherapy, and rehabilitation episodes, and all episodes 
in specialty hospitals.  We exclude true daycases, but not daycases which are transferred on 
to another department or hospital.  We exclude all surgical episodes (as explained in section 
5).  We drop high outliers with respect to LOS, following the approach proposed by Tukey 
(1977).   
Table  1  provides  summary  statistics  of  the  dependent  and  explanatory  variables.    The 
dependent  variables  adverse  drug  reactions,  infections  and  ulcers  are  binary  variables 
indicating whether a patient suffered one or several of the respective AE during an episode.  
Definitions are based on patient diagnoses codes (see Table 3).  They are comparably rare 
events.  Adverse drug reactions, and wound and nosocomial infections are based on external 
cause and specific injury codes, which by definition imply an AE (Jackson, Duckett et al. 
2006).  The codes for sepsis and ulcers follow the definition of patient safety indicators by 
the  US  Agency  for  Healthcare  Research  and  Quality  (2007;  Quan,  Drosler  et  al.  2009).  
Infections also comprise urinary tract infections, pneumonia, and respiratory tract infections, 
because they are usually considered complications of hospital care (Ehsani, Jackson et al. 
2006).  We do include patients who are coded with an AE as primary diagnosis and who may 
have acquired the condition before admission, for example, in another  department of the 
same hospital, another hospital or physician‘s practice.  It has been estimated that this affects 9 
 
about 14.9% of all adverse events (de Vries, Ramrattan et al. 2008).  This implies that we 
cannot attribute the AE to the treating hospital, but this is not objective of our study.   
LOS is a continuous variable measured as days of stay.  Other explanatory variables mostly 
characterize medical complexity of the patient, and episode characteristics.  The variables 
severity1, severity2, severity3 are medical complexity grades based on patients‘ diagnoses 
and procedures undertaken (Department of Health 2005).  We further adjust for patients‘ 
medical  complexity  by  including  17  comorbidities  as  defined  in  the  Charlson  index  as 
separate dummy variables, to allow for their differing impact on AEs (Charlson, Pompei et al. 
1987; Stagg 2006).  The Charlson index reflects the cumulative increase in likelihood of one-
year mortality due to the severity of the effect of comorbidities.  Because of high degree of 
correlation between ‗cancer‘ and ‗metastatic cancer‘, and ‗mild liver disease‘ and ‗severe 
liver disease‘ respectively, we code two new categories ‗liver disease‘ and ‗cancer‘ which 
comprise  both  the  less  and  the  more  serious  conditions.    AEs  may  not  be  independent 
occurrences  in  one  hospital;  for  example,  infections  may  spread  across  patients,  faulty 
medical  equipment  may  be  used  on  several  patients,  hospital  management  affects 
implementation  and  execution  of  safety  procedures,  or  –in  rare  cases-  incompetence  of 
medical staff may lead to AEs in several patients.  To control for such hospital specific 
effects,  we  include  separate  dummy  variables  for  all  33  hospitals  with  more  than  1500 
medical admissions in at least one year, with all smaller hospitals as reference category. 
 
5. The Instruments 
Instruments for LOS are dummy variables indicating the day of the week and month of the 
year the patient is discharged (see Table 2).  For the instruments to be relevant,  i LOS  and the 
instruments  i Z  need to be correlated in the reduced form equation, after partialling out  i X .  
There  is  evidence  that  hospital  operational  processes  and  differences  in  staffing  levels 
between weekdays and weekends lead to differences in LOS depending on the day of the 
week a patient is discharged (Schmidt, Taeger et al. 2003; Fonarow, Abraham et al. 2008; 
Wong, Wu et al. 2009).  Towards the end of the week, discharge rates are higher, early 
discharge more likely, and consequently LOS lower.  This may be explained by the attempt 
of hospital administrators to relieve pressure on reduced staffing levels at weekends.  On 
weekends, on the other hand, patients ready to be discharged may be held over until Monday 10 
 
due  to  lack  of  senior  staff  authorized  to  take  discharge  decisions.    This  could  explain 
observed  lower  discharge  rates  on  weekends,  higher  discharge  rates  on  Mondays,  and 
consequently longer LOS for patients discharged on Mondays.  Table 2 shows that half as 
many patients are discharged on Saturdays, Sundays and public holidays.  A second set of 
instruments is provided by month of discharge.  LOS is likely to be affected by variations in 
staffing levels across the year and the impact of holiday periods in some months, such as 
Christmas and Easter.  LOS may be lower in December due to the impending holiday and 
higher in January –which is the summer holiday period in Victoria- due to increased staff 
absences and patients kept in hospital for observation.  Also, seasonal variations in illness 
prevalence may impact on LOS.  Studies on the impact of month of admission (which is 
highly correlated with month of discharge) on LOS show considerable seasonal variability, 
with shortest LOS in July (equivalent to Victorian summer) and December (Schmidt, Taeger 
et al. 2003), and month of admission a significant predictor of LOS  (Stoskopf and Horn 
1992).   
Instrumental variable estimation is inconsistent if the instruments  i Z  and  1i e  are correlated in 
the structural equation.  This condition cannot be tested, and we need to rely on introspection 
to  defend  exogeneity  of  the  instruments,  i.e.  that  days  and  months  of  discharge  do  not 
influence the likelihood of suffering AEs.  There is no reason to assume that day of discharge 
should impact on AEs, as there is an obvious time sequence, with AEs occurring during the 
episode and discharge at the end.  However, day of admission may be associated with AEs, 
and captured by  1i e  in the structural equations.  If there were in addition a strong correlation 
between day of admission and discharge, implying a small standard deviation of LOS across 
the sample of patients,  i Z  and  1i e  may be correlated and the instruments endogenous.   
Previous  research  investigating  the  relationship  between  day  of  admission  and  health 
outcomes (usually not measured by AEs but mortality rates) has yielded conflicting results.  
Higher mortality rates on weekends has been found for patients requiring emergency surgery 
and emergency patients presenting with a limited range of conditions, but not for medical 
patients (Bell and Redelmeier 2001; Gogel, Liron et al. 2002; Arias, Taylor et al. 2004; Cram, 
Hillis et al. 2004; Becker 2007; Fonarow, Abraham et al. 2008; Schwierz, Augurzky et al. 
2009).  Dobkin (2003) shows that higher mortality rates on weekends can be explained by 
higher risk admissions.  After  controlling for this selection bias, the higher mortality  for 
patients admitted on weekends disappears.  This implies that patient complexity and not AEs 11 
 
are cause of poorer health outcomes on weekends.  It is possible that month of treatment may 
be endogenous because arrival of inexperienced junior staff at the beginning of the academic 
year may lead to worse health outcomes in that month (the ‗July phenomenon‘ in the USA).  
There is evidence for variations in outcomes for surgical (Englesbe, Pelletier et al. 2007; 
Haller,  Myles  et  al.  2009)  but  not  medical  admissions  (Barry  and  Rosenthal  2003; 
Finkielman, Morales et al. 2004). 
Following the above evidence, and to  err on the safe side and ensure that the exclusion 
restrictions are met, we exclude all surgical patients from our sample.  Correlation between 
day of admission and AEs is likely to be higher for surgical than medical patients, as elective 
(and perhaps even emergency) surgeries are more commonly scheduled at certain days of the 
week, whereas admissions of medical patients are likely to be more evenly distributed across 
the  week.    In  addition,  treatment  protocols  for  many  surgical  procedures  are  quite 
standardized, whereas this is less the case for medical admissions.  This is likely to result in 
lower variation in LOS and thus, higher correlation between day of admission and discharge 
for surgical patients.  We find evidence for this in our data.  The standard deviation of LOS 
for  all  medical  patients  in  Victorian  hospitals  in  2004/05  is  nearly  twice  as  high  as  for 
surgical  patients  with  a  similar  mean,  implying  a  smaller  correlation  between  day  of 
admission and discharge for medical patients.  In summary, relying on current evidence and 
using only medical patients, we are confident that the exclusion restrictions for both sets of 
instruments are met. 
 
6. Results and Discussion 
Estimates  of  the  effect  of  LOS  on  the  probability  of  experiencing  adverse  drug  events, 
infections and ulcers for both years are presented in Table 4.  Reported are the marginal or 
average effects (MEs or AVEs) and associated standard errors (SEs) for LOS from the system 
models, the p-values from the exogeneity tests, and results from univariate probits (UVPs) -
assuming LOS is exogenous- for comparison.  MEs, AVEs and SEs for all other explanatory 
variables and the hospital dummies from the system models are presented in Tables 5 and 6, 
respectively.  Coefficient estimates for the instruments from the first stage regressions for 
infections and results from F-tests of the joint significance are presented in Table 7 (Results 12 
 
for adverse drug events and ulcers are very similar).
3  Results from the UVPs for both years 
and  estimates  of     from  the  system  models  cannot  be  presented  here  due  to  space 
limitations.
3   
To check for endogeneity, we test whether or not there is significant correlation, H0:  0   , 
between the pseudo error terms  1i e  and  2i e  in the structural and reduced from equations.  This 
test of exogeneity is valid without assuming normality or homoskedasticity of the error  2i e  of 
the reduced form equation (Rivers and Vuong 1988).  Small p-values indicate that the null 
hypothesis of exogeneity of LOS is rejected for all but one model.  The results imply that 
LOS is endogenous for all models and years, except in 04/05, LOS is not endogenous in the 
model  for  adverse  drug  events.    For  this  model  only,  the UVP  with  LOS  as  exogenous 
regressors may be more appropriate. 
The instruments in the reduced form regressions are jointly significant (F-statistics 92.18 and 
94.81, see Table 7).  The separate F-statistics for ‗days of discharge‘ are much higher at 
279.64 (288.06) than for ‗months of discharge‘ at 5.55 (6.85), indicating that ‗months of 
discharge‘, if they were used on their own, may be weak instruments  (Staiger and Stock 
1997).    Coefficients  estimates  for  ‗days  of  discharge‘  are  all  significant  and  negative, 
decreasing  gradually  from  -0.09  (both  years)  for  Tuesday  to  -0.98  (0.94)  for  weekend 
discharges,  indicating  that  patients  discharged  on  Saturday  or  Sunday  have  nearly  1  day 
shorter LOS than patients discharged on Mondays.  The only months for which coefficient 
estimates are significant and -0.1 or smaller in both years are February, May, and December 
for both years, and in addition March, September, October and November for 05/06 only, 
indicating that patients discharged in those months stay at least 0.1 day shorter than patients 
discharged in January.  Impact of month of discharge on LOS is clearly less important than 
day of discharge, as coefficients on months are smaller and some even not significant.    
Estimates of the impact of LOS on all three types AEs and for both years are significant and 
positive, indicating that LOS increases the probability of experiencing AEs (see Table 4).  
The MEs and AVEs are evaluated at the mean of all regressors (discussed are results for 
04/05, with results for 05/06 in brackets).  Results from the system models indicate that each 
additional day in hospital increases the probability of suffering an adverse drug event by 
approximately 0.2% (0.4%), infection by 1.4% (1.6%), and ulcer by 0.3% (0.3%) (Due to the 
                                                           
3 available on the corresponding author‘s website. 13 
 
nonlinear nature of the models, MEs and AVEs may vary slightly according to where along 
the distribution of LOS they are evaluated).  MEs, AVEs and SEs generated by the UVPs are 
markedly smaller than the estimates generated by the system models.  If LOS is endogenous, 
the differences between UVP and system models may be attributable to bias of the UVP 
estimates.   
Hospital managers may not only be concerned with the increased risk due to one additional 
day in hospital (which is provided by the estimate of the MEs of LOS), but may want to 
compare treatment programs with LOS differences greater than one day.  As an example, an 
episode with total LOS of 4 days (3 nights) implies a total risk of suffering an adverse drug 
event of 0.8% (1.3%), infection of 4.8% (4.8%), and ulcer of 0.4% (0.8%).  An episode with 
LOS of 8 days (7 nights) implies a total risk of an adverse drug event of 1.9% (3.0%), 
infection of 11.1% (11.2%), and ulcer of 1.0% (1.9%), for the average patient and conditional 
on all other observable risk factors.   
To help put these numbers in perspective, other results of the model indicate that two patients 
who differed only in their age in that one is 40 years old and the other 60, ageing by 20 years 
increases the risk of adverse drug events by 5.8% (5.0%), infections by 4.5% (3.8%), and has 
no effect on ulcers (Table 5).  Being admitted as an emergency rather than an elective patient 
increases risk of adverse drug events by 1.6% (1.7%), infections by 7.3% (7.4%), and again 
does not affect ulcers.  Some patient comorbidities have considerable impact on the risk of 
suffering  AEs,  although  for  others  effects  are  surprisingly  small  or  even  insignificant.  
Focusing on the comorbidities with highest prevalence in our sample, congestive heart failure 
increases risk of adverse drug events by 0.8% (0.7%), infections by 4.1% (3.3%), and does 
not affect ulcers, in comparison to not suffering this comorbidity and holding all other factors 
constant.  Chronic obstructive pulmonary disease decreases risk of adverse drug events by 
0.6%  (04/05  only)  and  ulcers  by  0.1%  (0.3%),  which  are  counterintuitive  results,  but 
increases risk of infections by 1.2% (1.7%).  Diabetes increases risk of adverse drug reactions 
by 1.1% (0.6%), infections by 1.0% (only in 05/06) and ulcers by 0.2% (0.6%), whereas 
diabetes complications do not increase risk of any AE.  Cancer increases risk of adverse drug 
events by 2.0 (1.5%), infections by 2.7% (1.2%), and decreases risk of ulcers by -0.2% (only 
in 05/06).   
Comparably  high  AVEs  are  observed  for  hemiplegia/paraplegia,  and  aids.  
Hemiplegia/paraplegia decreases (surprisingly) risk of adverse drug events by -1.3% (-1.2%), 14 
 
increases risk of infections by 3.0% (3.2%), and ulcers by 1.7% (2.0%).  AIDS increases risk 
of adverse drug events by 8.0% (5.1%) and infections by 18.3% (21%).  To summarize the 
impact  of  comorbidities,  the  top  two  risk  factors  for  adverse  drug  events  are  AIDS  and 
rheumatoid  disease, maybe because patients  with  these comorbidities  receive  comparably 
drug-intensive  therapies.    Top  risk  factors  for  infections  are  AIDS  and  cerebrovascular 
events, and for ulcers are hemiplegia or paraplegia, which is not surprising considering that 
ulcers are much more likely to occur in immobile patients.  The MEs and AVEs discussed 
here only capture the direct effects of the exogenous regressors on AEs; in addition, there 
may be indirect effects via LOS, which together would sum up to a total effect.   
Average  effects  on  the  hospital  dummies  are  relatively  large,  indicating  that  the  treating 
hospital is as (if not more) important than LOS and patient level risk factors in explaining the 
probability of AEs (see Table 6).  AVEs for the hospitals vary from -1.5% to 9.6% (-0.6% to 
12.4%) for adverse drug events, -1.6 to 5.8% (-0.6% to 9.4%) for infections, and -0.5% to 
1.5% (-0.5% to 2.2%) for ulcers.  This implies that some patients experienced a much higher 
or lower risk of AEs just because they were admitted to a particular hospital rather than 
another.  This result should be interpreted with care, though, as the occurrence of the AE 
cannot  be  unambiguously  attributed  to  the  treating  hospital.    There  is  a  possibility  that 
patients are non-randomly transferred to this particular hospital after having suffered adverse 
drug events in other hospitals (or in the community), which may lead to above average rates 
of AEs in that hospital.  It is possible that the relatively large AVEs may be due to systematic 
differences in reporting AEs across hospitals.   
This study has several limitations.  LOS enters the models as a linear continuous variable.  
Thus,  we  assume  that  the  effect  of  increasing  the  hospital  stay  by  one  day  is  the  same 
irrespective of how long the patient has already stayed in hospital, and any nonlinearity is 
attributable to the model specification.  It is a relatively strong assumption that increasing the 
hospital stay from (say) 2 to 3 days leads to the same increase in risk than increasing the 
hospital stay from (say) 13 to 14 days.  We estimate UPVs with the squared values of LOS as 
additional regressors to check for nonlinearity, and coefficient estimates are very small but 
significant,  which  may  indicate  nonlinearity.
3  Future  research  could  explore  alternative 
models specifications with LOS as a nonlinear variable, or the use of semi- or nonparametric 
models which impose hardly any or no functional assumptions on LOS.   15 
 
Another, related, limitation is that we do not know at what day during the episode the AE 
occurs, as our data do not record this.  We assume that medical AEs may happen anytime 
during the episode, but the likelihood may not be uniformly distributed, and may also differ 
by type of AE.  There is an argument that adverse drug events are most likely to happen at the 
beginning of episode, because decisions on medication regimes (and thus therapeutic errors) 
are most often made at the time the patient is admitted.  Some type of infections may also be 
more likely to occur at the beginning of the episode, because patients could be sicker initially 
and thus more susceptible for infections.  The likelihood of developing ulcers is strongly 
influenced by the length of time a patient is immobile, and thus unlikely to occur at the 
beginning  of  the  episode,  unless  the  patient  is  admitted  with  it  (Agency  for  Healthcare 
Research  and  Quality  2007).    This  may  imply  that  the  probability  of  developing  ulcers 
increases exponentially with LOS.  In summary, our estimate of the marginal effect of LOS 
on AE averages across the episode, and may over- or underestimate the risk at particular days 
during the episode.   
Unlike the impact of LOS on AEs, the reverse of the relationship, the impact of AEs on LOS, 
has been studied relatively extensively, because LOS is used as a proxy of costs in models 
which measure the resource implications of AEs (Zhan and Miller 2003; Graves, Birrell et al. 
2005; Graves, Weinhold et al. 2007; Nuckols, Paddock et al. 2008).  Results vary greatly by 
study and type of AE, but overall, there is evidence that most types of AEs are associated 
with longer LOS.  This demonstrates that there is the strong intuition that LOS is endogenous 
in  models  of  AEs,  and  AEs  endogenous  in  models  of  LOS,  i.e.  that  AEs  and  LOS  are 
simulatenously determined.  Ideally, LOS and AEs should be modelled jointly, for example, 
in a simultaneous equation model.  However, this would require instruments for both LOS 
and AEs.  As instruments for AEs are not available in our dataset, we need to limit the 
objective of our paper on estimating the impact of LOS on the incidence of AEs.   
 
7. Conclusions 
We use a statistical model to estimate the incidence of three types of medical AEs as a 
function of patient risk factors, hospital effects, and LOS using administrative hospital data.  
Our research complements previous research efforts, which are mainly qualitative because 
they  rely  on  retrospective  patient  record  reviews  by  medical  experts.    Our  particular 
contribution is to provide structural estimates of the impact of LOS on the incidence of AE, 16 
 
accounting for the possibility that LOS is endogenous with a structural equation model and 
additional  instruments  for  LOS.    We  find  that  LOS  increases  the  probability  of  AEs  at 
comparable magnitudes to other risk factors such as age, being an emergency patient, or 
suffering of significant comorbidities.  However, in contrast to patient risk factors, LOS is a 
hospital-level risk factors which is directly amenable to the actions of hospital management; 
patients can be discharged earlier, and part or all of the stay in hospital can be substituted by 
stays at alternative care providers, or at home.  This may be beneficial if it significantly 
lowers risk of AEs.  Although it is more satisfactory to address hospital-level causal reasons 
for the occurrence of AEs, such as poor safety procedures, LOS may be the only factor which 
can be changed in the short run and under relatively low costs.  Our results provide hospital 
managers with the quantitative evidence to take informed discharge and care decisions.   
Our results provide managers with an estimate of the expected risk of AE due to an additional 
day in hospital, but they also allow comparing treatment programs which differ substantially 
with respect to AE and LOS.  Expected costs of AE for the average patient episode can be 
obtained  by  multiplying  our  estimate  of  the  probability  of  AE  for  an  episode  of  mean 
duration with cost estimates such as the ones generated by Zhan and Miller (2003).  Using 
their  estimates  of  excess  charges  caused  by  infections  due  to  medical  care  and  ulcers 
(estimates for adverse drug events are not provided), our results imply that the expected costs 
of AE are about US $5,265 for infections and US $78 for ulcers, per episode and for the 
average patient.  These are rough estimates of the extra health care costs due to AE, and they 
do not consider the costs of excess morbidity and mortality.   
The risk of AE is of course not the only factor which should influence discharge decisions.  
However, considering the relatively large expected costs of AE, it seems timely that they are 
factored into discharge and treatment decisions in a quantitative way.  Our statistical model 
of  AEs  can  contribute  to  providing  such  quantitative  evidence,  and  offers  important 
additional information to the qualitative research efforts on incidence and risk factors of AE.  
It  proposes  an  alternative  to  randomized  controlled  trials  for  comparing  treatments  with 
different discharge policies, which are not well equipped to deal with endogeneity, and are 
more expensive.  It contributes to providing a sound evidence base for analysing incidence 
and  risk  factors  of  AEs,  and  the  implementation  of  system  level  approaches  for  the 
prevention of AEs in hospitals.   
   17 
 
 
Table 1: Summary statistics of dependent and explanatory variables 
 
 
   2004/5  2005/6 
 
Mean  SD  Mean  SD 
total observations  198,854  206,489 
Adverse events         
adverse drug reactions  0.050  0.217  0.051  0.219 
infections  0.172  0.377  0.170  0.375 
ulcers  0.012  0.107  0.013  0.112 
Explanatory variables           
LOS  5.46  5.29  5.37  5.19 
age   59.13  22.06  59.08  22.14 
non-elective  0.745  0.436  0.747  0.435 
number of procedures  1.79  2.02  1.83  2.05 
female  0.568  0.495  0.571  0.495 
discharge by death  0.030  0.170  0.029  0.167 
severity grade 1  0.389  0.488  0.383  0.486 
severity grade 2  0.489  0.500  0.495  0.500 
severity grade 3  0.122  0.327  0.122  0.328 
Charlson comorbidities           
acute myocardial infarction (ami)  0.036  0.186  0.038  0.191 
congestive heart failure (chf)  0.080  0.272  0.079  0.270 
peripheral vascular disease (pvd)  0.016  0.127  0.017  0.130 
cerebrovascular event (cevd)  0.049  0.216  0.049  0.216 
dementia  0.036  0.186  0.035  0.185 
chronic obstructive pulmonary disease (copd)  0.080  0.272  0.079  0.269 
rheumatoid disease (rheuma)  0.006  0.074  0.006  0.076 
peptic ulcer (pud)  0.002  0.049  0.002  0.046 
liver disease*  0.010  0.098  0.010  0.102 
diabetes  0.073  0.260  0.068  0.252 
diabetes complications (diab comp)  0.109  0.312  0.120  0.325 
hemiplegia or paraplegia (hp papl)  0.028  0.166  0.029  0.166 
renal disease  0.065  0.246  0.069  0.254 
cancer^  0.082  0.273  0.082  0.274 
aids  0.001  0.038  0.002  0.040 
 
----------------------------------------------------- 
* includes patients with severe liver disease 
^ includes patients with metastatic cancer 
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Table 2: Summary statistics of the instruments 
 
   2004/5  2005/6 
 
Mean  SD  Mean  SD 
Days of discharge         
Monday*  0.183  0.387  0.188  0.391 
Tuesday  0.158  0.365  0.157  0.363 
Wednesday  0.159  0.365  0.161  0.368 
Thursday  0.163  0.369  0.159  0.366 
Friday^  0.188  0.391  0.192  0.394 
Weekend (Saturday or Sunday)
+ #  0.190  0.393  0.198  0.398 
          Months of discharge          January  0.080  0.272  0.082  0.275 
February  0.076  0.265  0.076  0.266 
March  0.085  0.279  0.087  0.281 
April  0.082  0.275  0.078  0.268 
May  0.085  0.280  0.087  0.282 
June  0.084  0.278  0.083  0.276 
July  0.084  0.278  0.084  0.278 
August  0.085  0.279  0.087  0.282 
September  0.085  0.279  0.084  0.277 
October  0.085  0.279  0.084  0.278 
November  0.082  0.275  0.083  0.275 
December  0.085  0.278  0.084  0.278 
 
------------------------------- 
* also discharges on days after a public holiday 
^ also discharges on days before a public holiday 
+ also discharges on public holidays, on Mondays before a holiday falling on a Tuesday, and Fridays after a holiday falling 
on a Thursday 
# differences in holidays across regional and metropolitan Victoria are considered 
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Table 3: ICD10-AM adverse events codes 
 
Adverse drug reactions   
Y400-Y599  Drugs causing adverse effects in therapeutic use 
Y630-Y639  Failure in dosage during medical care 
Y601-Y603  Cut during infusion, dialysis or injection 
Y621-Y623  Failure of sterile precautions during infusion, dialysis or injection 
Y640-Y649  Contaminated medical or biological substance administered 
Y650  Mismatched blood 
Y651  Wrong fluid in infusion 
T881  Rash following immunization 
T886  Anaphylactic shock due to adverse effect of correct drug or medicament properly 
administered  T887  Unspecified adverse effect of drug or medicament 
Infections   
Wound infections   
T814  Infection following a procedure, not elsewhere classified or post operative 
infection, wound  T793  Post-traumatic wound infection, not elsewhere classified 
T826-T827 , T835-T836 , T845-
T847, T857  
Infection and inflammatory reaction due to prosthetic devices, implants and grafts 
T802  Infections following infusion, transfusion and therapeutic injection 
T880  Infection following immunization 
 
Y95  Nosocomial condition 
 
Urinary tract infections   
N390  UTI 
Pneumonia and lower respiratory tract infections 
J120-J189  Pneumonia 
J200-J22  Lower respiratory tract infection 
Sepsis   
A400-A419  Streptococcal and other septicaemia 
R578  Endotoxic shock 
T811  Shock during or resulting from a procedure, not elsewhere classified 
Pressure ulcers   
L89  Decubitus ulcer 
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Table 4: Summary of results from system and univariate probit models 
 
 
Adverse drug events  Infections  Ulcers 
ME* of LOS  SE  ME* of LOS  SE  ME* of LOS  SE 
2004/5 
UVP  .00195  .00008  .00685  .00016  .00049  .00002 
System model  .00248  .00118  .01449  .00236  .00271  .00102 
Test of exogeneity (rho 
= 0) Prob > chi2  0.6456  0.0010  0.0001 
2005/6 
UVP  .00184  .00008  .00723  .00016  .00048  .00002 
System model  .00427  .00125  .01601  .00228  .00276  .00099 
Test of exogeneity (rho 
= 0) Prob > chi2  0.0419  0.0001  0.0001 
 
------------------------------ 
* Marginal effects are evaluated at the mean of all regressors. 
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Table 5: Marginal and average effects for patients’ explanatory variables from the  








adverse drug events  infections  ulcers 
 
2004/05  2005/06  2004/05  2005/06  2004/05  2005/06 
Prob. of AE  0.043  0.040  0.164  0.141  0.006  0.009 
variables  dy/dx^  SE  dy/dx^  SE  dy/dx^  SE  dy/dx^  SE  dy/dx^  SE  dy/dx^  SE 
age  0.003  0.000  0.003  0.000  0.002  0.000  0.002  0.000  0.000  0.000  0.000  0.000 
age2  0.000  0.000  0.000  0.000  0.000  0.000  0.000  0.000  0.000  0.000  0.000  0.000 
female*  0.009  0.001  0.008  0.001  0.012  0.002  0.015  0.002  -0.001  0.000  -0.001  0.000 
non-elective*  0.016  0.001  0.017  0.001  0.073  0.002  0.074  0.002  0.000  0.000  0.000  0.001 
number of 
procedures 
0.001  0.002  -0.002  0.002  -0.002  0.003  -0.004  0.003  -0.001  0.001  -0.002  0.001 
severity grade 1*  -0.003  0.001  -0.007  0.001  0.077  0.003  0.062  0.003  -0.002  0.001  -0.002  0.001 
severity grade 3*  -0.010  0.001  -0.009  0.001  -0.018  0.003  -0.020  0.003  0.002  0.001  0.003  0.001 
discharge by death*  -0.016  0.002  -0.013  0.002  0.089  0.007  0.080  0.006  excluded
#  0.017  0.002 
ami*  -0.008  0.002  -0.007  0.002  0.004  0.005  0.019  0.004  -0.002  0.001  -0.003  0.001 
chf*  0.008  0.003  0.007  0.002  0.041  0.005  0.033  0.004  -0.001  0.001  -0.001  0.001 
pvd*  -0.019  0.002  -0.010  0.002  -0.067  0.005  -0.048  0.004  0.006  0.001  0.006  0.002 
cevd*  -0.023  0.002  -0.018  0.002  -0.083  0.004  -0.073  0.003  -0.005  0.001  -0.007  0.001 
dementia*  -0.016  0.003  -0.019  0.002  0.021  0.008  0.023  0.007  0.003  0.001  0.001  0.001 
copd*  -0.006  0.002  -0.001  0.002  0.012  0.003  0.017  0.003  -0.001  0.001  -0.003  0.001 
rheuma*  0.034  0.008  0.027  0.007  -0.012  0.011  0.000  0.010  0.002  0.002  0.004  0.003 
pud*  0.021  0.010  0.014  0.009  -0.034  0.014  -0.049  0.012  -0.002  0.002  0.000  0.003 
liver disease*  -0.004  0.003  -0.008  0.003  -0.008  0.007  -0.009  0.006  0.001  0.001  -0.003  0.001 
diabetes*  0.011  0.002  0.006  0.002  0.006  0.004  0.010  0.003  0.002  0.001  0.006  0.001 
diab comp*  0.001  0.001  0.002  0.001  0.004  0.003  0.003  0.002  0.000  0.000  0.000  0.001 
hp papl*  -0.013  0.003  -0.012  0.003  0.030  0.008  0.032  0.007  0.017  0.003  0.020  0.003 
renal disease*  0.026  0.003  0.012  0.002  0.041  0.004  0.037  0.004  0.000  0.001  -0.001  0.001 
cancer*  0.020  0.002  0.015  0.002  0.027  0.004  0.012  0.004  -0.001  0.001  -0.002  0.001 





* dy/dx is for a discrete change of dummy variable from 0 to 1. 
^ Marginal and average effects are evaluated at the mean of all regressors. 
# ‗death‘ is excluded due to high degree of collinearity with other explanatory variables.  
$ there are no AIDS patients with ulcers. 
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adverse drug events  infections  ulcers 
 
2004/05  2005/06  2004/05  2005/06  2004/05  2005/06 
Hospital dummies  dy/dx^  SE  dy/dx^  SE  dy/dx^  SE  dy/dx^  SE  dy/dx^  SE  dy/dx^  SE 
A17*  0.051  0.006  0.055  0.006  0.056  0.008  0.049  0.007  0.008  0.003  0.013  0.004 
A32*  0.037  0.006  0.029  0.006  0.009  0.008  -0.006  0.007  0.001  0.002  -0.001  0.002 
B01*  0.064  0.010  0.068  0.011  0.058  0.012  0.046  0.011  0.000  0.002  0.004  0.004 
B03*  0.037  0.004  0.058  0.006  0.035  0.006  0.034  0.006  0.001  0.001  0.008  0.003 
B05*  0.027  0.004  0.041  0.005  0.010  0.006  0.009  0.005  -0.003  0.001  -0.002  0.001 
B11*  0.049  0.006  0.048  0.006  0.043  0.007  0.032  0.007  0.004  0.002  0.010  0.004 
B18*  0.035  0.004  0.028  0.005  0.018  0.006  0.012  0.006  -0.002  0.001  0.000  0.001 
B21*  0.000  0.003  0.016  0.004  -0.008  0.006  0.003  0.005  -0.003  0.001  -0.002  0.001 
B22*  0.096  0.012  0.124  0.014  0.056  0.014  0.094  0.014  0.006  0.004  0.012  0.006 
B28*  0.015  0.004  0.009  0.004  0.031  0.007  0.027  0.007  0.000  0.001  0.006  0.003 
B33*  0.025  0.005  0.035  0.005  -0.007  0.006  0.019  0.007  0.001  0.001  0.004  0.002 
B36*  0.006  0.006  0.017  0.007  0.034  0.010  0.015  0.009  -0.003  0.001  -0.005  0.001 
B39*  0.016  0.005  0.016  0.005  0.025  0.008  0.025  0.007  0.001  0.002  0.008  0.003 
B45*  -0.003  0.003  0.014  0.004  -0.012  0.006  0.010  0.006  0.001  0.001  0.006  0.003 
B66*  0.055  0.016  0.040  0.008  0.049  0.020  0.049  0.010  0.015  0.008  0.020  0.007 
D01*  0.005  0.005  0.011  0.005  0.009  0.008  0.005  0.007  0.001  0.002  0.007  0.003 
D02*  0.007  0.004  0.004  0.004  0.011  0.007  0.002  0.006  -0.002  0.001  0.000  0.002 
D05*  0.021  0.004  0.036  0.004  -0.008  0.005  -0.004  0.005  0.003  0.001  0.005  0.002 
D06*  0.038  0.008  0.025  0.007  0.015  0.011  0.013  0.009  0.004  0.003  0.007  0.004 
D07*  0.027  0.008  0.028  0.008  -0.008  0.011  0.012  0.011  0.007  0.004  0.004  0.004 
D12*  0.027  0.005  0.022  0.005  -0.016  0.007  0.008  0.007  -0.001  0.001  -0.002  0.001 
D15*  0.025  0.007  0.029  0.007  0.016  0.010  0.053  0.010  0.003  0.002  0.002  0.003 
D16*  0.047  0.006  0.050  0.006  0.001  0.008  -0.003  0.007  0.004  0.002  0.003  0.002 
D17*  0.061  0.010  0.068  0.011  0.011  0.011  0.022  0.011  -0.002  0.002  0.016  0.007 
E04*  0.032  0.007  0.030  0.007  0.030  0.009  0.038  0.009  0.001  0.002  0.004  0.003 
E18*  -0.015  0.005  -0.006  0.005  0.017  0.011  0.025  0.010  -0.001  0.002  -0.005  0.002 
E22*  0.014  0.004  0.009  0.004  0.026  0.007  0.040  0.007  0.014  0.004  0.018  0.005 
E44*  0.021  0.005  0.016  0.005  0.050  0.009  0.036  0.007  0.009  0.003  0.004  0.002 
E58*  0.034  0.008  0.025  0.007  0.029  0.011  0.058  0.011  0.008  0.003  0.019  0.006 
E59*  0.004  0.005  0.019  0.006  0.013  0.009  0.017  0.008  -0.001  0.001  0.003  0.003 
E66*  0.057  0.009  0.050  0.008  0.021  0.011  0.020  0.009  0.001  0.002  0.006  0.004 
G25*  0.003  0.005  -0.003  0.004  0.016  0.008  0.028  0.008  0.009  0.003  0.022  0.006 
P32*  -0.002  0.005  0.003  0.005  0.020  0.009  0.019  0.008  -0.005  0.001  -0.004  0.002 
 
--------------------------------------------- 
* dy/dx is for a discrete change of dummy variable from 0 to 1 
^ Average effects are evaluated at the mean of all regressors. 
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Table 7: Coefficient estimates for the instruments from the system models for  
infections^ (first stage regressions) 
 
 
2004/05  2005/06 
Instruments  β  SE  β  SE 




Tuesday  -0.088*  0.033  -0.087*  0.032 
Wednesday  -0.341*  0.033  -0.401*  0.032 
Thursday  -0.537*  0.033  -0.526*  0.032 
Friday  -0.721*  0.032  -0.727*  0.030 
Weekend (Saturday or Sunday)  -0.983*  0.031  -0.944*  0.030 








February  -0.137*  0.048  -0.124*  0.046 
March  -0.029  0.047  -0.188*  0.045 
April  -0.040  0.047  0.030  0.046 
May  -0.153*  0.047  -0.148*  0.045 
June  -0.034  0.047  -0.002  0.045 
July  -0.008  0.047  -0.080  0.045 
August  0.104  0.047  0.009  0.045 
September  -0.034  0.047  -0.108*  0.045 
October  -0.024  0.047  -0.174*  0.045 
November  0.022  0.047  -0.126*  0.045 
December  -0.175*  0.047  -0.214*  0.045 
 
------------------------------------------ 
^ coefficient estimates from the first stage regressions are very similar for adverse drug reactions and ulcers (available on 
request) 
* significant at 95% confidence level 
coefficient estimates for additional explanatory variables in the first stage regression are not reported, but available on 
request. 
 
F-tests of the joint significance of the instruments for infections (results for adverse drug reactions and ulcers are 
very similar, and available on request): 
Days and months of discharge: F(16,198776) = 92.18 for 2004/05; F(16,206414) = 94.81 for 2005/06. 
Days of discharge only: F(5,198776) = 279.64 for 2004/05 for 2004/05; F(5,206414) = 288.06 for 2005/06. 
Months of discharge only: F(11,198776) = 5.55 for 2004/05; F(11,206414) = 6.85 for 2005/06. 
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